10月14日，新华社发表题为《坚持党的全面领导 为实现高质量发展提供根本保证——“十四五”时期经济社会发展实践与启示述评之一》文章。明确指出培育新质生产力已成全党全社会共识，高性能装备、增材制造等关键核心技术持续突围。

CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its proprietary, non-animal recombinant human collagen ...

Advances in regenerative medicine are transforming how we approach tissue and organ repair, offering patient-specific and functional alternatives to ...

Three-dimentional (3D) bioprinting has revolutionized tissue engineering by enabling the in vitro assembly of cells, proteins, and microenvironments into precise 3D biostructures. This technology ...

Researchers in Germany have created a groundbreaking 3D printer designed to print living tissue in the body through tiny ...

In the 3D printing world, 2021 is shaping up to be the year of bioprinting, with both 3D Systems (NYSE: DDD) and Desktop Metal (NYSE: DM) entering the commercial bioprinting market this year.

CTIBIOTECH™, a leading innovator in human tissue engineering and 3D bioprinting, is proud to announce its selection by SATT AxLR and CILCARE to support the development of the OrgaEar project. This ...

In the 3D printing world, 2021 is shaping up to be the year of bioprinting, with both 3D Systems (DDD-1.62%) and Desktop Metal (DM) entering the commercial bioprinting market this year. Bioprinting ...

An in-depth look at the leading 3D printing stocks in the U.S stock market this year. Here’s what you need to know.